Roka Bioscience to Present at the 29th Annual Roth Conference

WARREN, N.J., March 10, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ:ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens,  today announced that Mary Duseau, CEO will present at the 29^th Annual Roth Conference on March 14 at 8:00am PT. The conference will be held at The Ritz –Carlton, Dana Point CA.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies.  For more information, visit http://rokabio.com.

Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-present-at-the-29th-annual-roth-conference-300421537.html

SOURCE Roka Bioscience, Inc.